Average Co-Inventor Count = 9.99
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (12 from 2,405 patents)
2. Merck Sharp & Dohme LLC (1 from 11 patents)
13 patents:
1. 12516046 - 2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors
2. 12195445 - 2-amino-N-heteroaryl-nicotinamides as Na1.8 inhibitors
3. 11680060 - Bicycloheptane pyrrolidine orexin receptor agonists
4. 11377438 - 2-amino-n-heteroaryl-nicotinamides as Na1.8 inhibitors
5. 11332463 - Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors
6. 11098029 - 5-alkyl pyrrolidine orexin receptor agonists
7. 10870630 - Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors
8. 10214546 - Btk inhibitors
9. 10208047 - Tertiary alcohol imidazopyrazine BTK inhibitors
10. 10130630 - BTK inhibitors
11. 10087188 - Benzamide imidazopyrazine Btk inhibitors
12. 10040805 - Substituted imidazo[1,5-a]pyrazines as Btk inhibitors
13. 9840481 - Allosteric modulators of nicotinic acetylcholine receptors